Check Point Software Technologies.../ IL0010824113 /
| 2024-04-26 9:59:58 PM | Chg. -1.71 | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 151.13USD | -1.12% | 79,588 Turnover: 12.07 mill. |
-Bid Size: - | -Ask Size: - | 17.68 bill.USD | - | 21.03 |
GlobeNewswire
04-26
Robbins LLP Reminds Stockholders of CKPT to Contact the Law Firm for Information About the Checkpoin...
Newsfile Corp
04-25
ROSEN, A TOP RANKED LAW FIRM, Encourages Checkpoint Therapeutics, Inc. Investors to Secure Counsel B...
GlobeNewswire
04-25
DEADLINE ALERT for HRT, CKPT, and SOND: The Law Offices of Frank R. Cruz Reminds Investors of Class ...
GlobeNewswire
04-25
Medigene presents streamlined 6-day, high stemness TCR-T therapy production process
GlobeNewswire
04-25
Purple Biotech's Randomized Phase 2 CM24 Pancreatic Cancer Study Selected as Late-Breaking Abstract ...
GlobeNewswire
04-25
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Che...
GlobeNewswire
04-24
NANOBIOTIX Provides Business Update and Reports Full Year 2023 Financial Results
GlobeNewswire
04-24
23andMe to Present Preliminary Efficacy and Biomarker Data for 23ME-00610 at the 2024 American Socie...
GlobeNewswire
04-24
Sensei Biotherapeutics to Present Topline Clinical Data from the SNS-101 Phase I Dose Escalation Stu...
GlobeNewswire
04-24
DEADLINE ALERT for HRT, CKPT, SOND, QDEL: Law Offices of Howard G. Smith Reminds Investors of Class ...
GlobeNewswire
04-24
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Checkp...
GlobeNewswire
04-24
SHAREHOLDER ACTION NOTICE: The Schall Law Firm Encourages Investors in Checkpoint Therapeutics, Inc....
GlobeNewswire
04-24
BioXcel Therapeutics Announces Late-Breaking Abstract on Preliminary Findings from Phase 2 Investiga...
GlobeNewswire
04-24
Cullinan Therapeutics to Present Clinical Data from Phase 1 Study Evaluating Novel Anti-MICA/B Antib...
GlobeNewswire
04-24
Regeneron to Showcase Progress in Advancing Novel Investigational Treatment Approaches for a Broad R...
GlobeNewswire
04-24
Werewolf Therapeutics Announces WTX-124 Clinical Abstract Accepted for Presentation at the 2024 Amer...
GlobeNewswire
04-24
ALX Oncology Announces Two Evorpacept Abstracts Accepted for Poster Presentation at 2024 ASCO Annual...
GlobeNewswire
04-24
Affimed Announces Acceptance of AFM24 Clinical Abstract at the 2024 Annual Meeting of the American S...
GlobeNewswire
04-23
OncoC4 Announces FDA Clearance of IND Application for Novel SIGLEC 10 Immune Checkpoint Inhibitor ON...
GlobeNewswire
04-23
PDS Biotech to Host Key Opinion Leader Event to Discuss Positive, Updated Data from Phase 2 VERSATIL...
